1. Home
  2. SCS vs VIR Comparison

SCS vs VIR Comparison

Compare SCS & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCS
  • VIR
  • Stock Information
  • Founded
  • SCS 1912
  • VIR 2016
  • Country
  • SCS United States
  • VIR United States
  • Employees
  • SCS N/A
  • VIR N/A
  • Industry
  • SCS Office Equipment/Supplies/Services
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCS Consumer Discretionary
  • VIR Health Care
  • Exchange
  • SCS Nasdaq
  • VIR Nasdaq
  • Market Cap
  • SCS 1.2B
  • VIR 1.4B
  • IPO Year
  • SCS 1998
  • VIR 2019
  • Fundamental
  • Price
  • SCS $11.19
  • VIR $6.48
  • Analyst Decision
  • SCS Strong Buy
  • VIR Buy
  • Analyst Count
  • SCS 2
  • VIR 6
  • Target Price
  • SCS $17.00
  • VIR $35.67
  • AVG Volume (30 Days)
  • SCS 830.9K
  • VIR 1.3M
  • Earning Date
  • SCS 03-26-2025
  • VIR 05-01-2025
  • Dividend Yield
  • SCS 3.60%
  • VIR N/A
  • EPS Growth
  • SCS 50.00
  • VIR N/A
  • EPS
  • SCS 1.02
  • VIR N/A
  • Revenue
  • SCS $3,166,000,000.00
  • VIR $74,205,000.00
  • Revenue This Year
  • SCS $3.00
  • VIR N/A
  • Revenue Next Year
  • SCS $3.07
  • VIR $17.69
  • P/E Ratio
  • SCS $10.88
  • VIR N/A
  • Revenue Growth
  • SCS 0.20
  • VIR N/A
  • 52 Week Low
  • SCS $10.30
  • VIR $6.40
  • 52 Week High
  • SCS $14.74
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • SCS 44.25
  • VIR 32.44
  • Support Level
  • SCS $10.30
  • VIR $6.40
  • Resistance Level
  • SCS $11.70
  • VIR $7.26
  • Average True Range (ATR)
  • SCS 0.32
  • VIR 0.32
  • MACD
  • SCS 0.02
  • VIR 0.02
  • Stochastic Oscillator
  • SCS 45.00
  • VIR 28.44

About SCS Steelcase Inc.

Steelcase Inc is a furniture company based in the United States. Its brands such as Steelcase, AMQ, Coalesse, Designtex, and others offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas which generates key revenue, and International.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: